全文获取类型
收费全文 | 1444篇 |
免费 | 107篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 81篇 |
妇产科学 | 19篇 |
基础医学 | 176篇 |
口腔科学 | 38篇 |
临床医学 | 186篇 |
内科学 | 292篇 |
皮肤病学 | 31篇 |
神经病学 | 44篇 |
特种医学 | 317篇 |
外科学 | 152篇 |
综合类 | 24篇 |
预防医学 | 56篇 |
眼科学 | 14篇 |
药学 | 48篇 |
中国医学 | 8篇 |
肿瘤学 | 63篇 |
出版年
2023年 | 15篇 |
2021年 | 25篇 |
2020年 | 13篇 |
2019年 | 19篇 |
2018年 | 31篇 |
2017年 | 18篇 |
2016年 | 25篇 |
2015年 | 34篇 |
2014年 | 44篇 |
2013年 | 41篇 |
2012年 | 54篇 |
2011年 | 48篇 |
2010年 | 49篇 |
2009年 | 64篇 |
2008年 | 48篇 |
2007年 | 34篇 |
2006年 | 35篇 |
2005年 | 24篇 |
2004年 | 33篇 |
2003年 | 36篇 |
2002年 | 25篇 |
2001年 | 31篇 |
2000年 | 23篇 |
1999年 | 23篇 |
1998年 | 53篇 |
1997年 | 57篇 |
1996年 | 69篇 |
1995年 | 54篇 |
1994年 | 45篇 |
1993年 | 51篇 |
1992年 | 27篇 |
1991年 | 11篇 |
1990年 | 33篇 |
1989年 | 47篇 |
1988年 | 45篇 |
1987年 | 43篇 |
1986年 | 35篇 |
1985年 | 27篇 |
1984年 | 19篇 |
1983年 | 13篇 |
1982年 | 23篇 |
1981年 | 16篇 |
1980年 | 10篇 |
1979年 | 6篇 |
1978年 | 6篇 |
1977年 | 13篇 |
1976年 | 12篇 |
1975年 | 18篇 |
1972年 | 5篇 |
1971年 | 5篇 |
排序方式: 共有1559条查询结果,搜索用时 15 毫秒
1.
Barbara S Morgan Charles P Buscemi Vivian P Fajardo 《Journal of transcultural nursing》2004,15(2):139-146
The purposes of this pilot study were to identify and adapt instruments for future use in assessing diabetes self-management in a sample of Cuban Americans with Type 2 diabetes. Eight instruments were selected from the literature, translated into Spanish, and administered to a sample of 20 Cuban Americans with Type 2 diabetes. Psychometric properties were examined along with clarity of wording, cultural appropriateness, and ease of use. Reliability data were compared, when possible, with original scores generated with non-Cuban populations. Results indicated that reliability scores among populations were similar. Support for using these instruments in clinical practice to assess initial knowledge and beliefs about aspects of diabetes management and to monitor changes is provided. 相似文献
2.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
3.
E M Sacks L L Fajardo B J Hillman G W Drach J A Gaines H R Claypool N J Clinger D J Fillmore K R Hunt G D Pond 《The Journal of urology》1990,144(6):1341-1346
Most publications citing the effectiveness of renal extracorporeal shock wave lithotripsy have used plain abdominal radiography to assess residual calculi after treatment. We compared radiologist sensitivity and specificity in the detection of calculi on plain abdominal radiographs versus conventional film-screen and digital renal tomograms in extracorporeal shock wave lithotripsy patients. Of the patients 50 were imaged before and within 24 hours after lithotripsy. Six radiologists evaluated the resultant 300 studies for the presence and location of calculi. The mean sensitivity for digital tomograms was 83% for pre-lithotripsy and post-lithotripsy studies, which was significantly higher than for plain abdominal radiography and conventional tomography after lithotripsy. However, there were significantly more false positive stone diagnoses associated with digital tomogram interpretation. Signal detection analysis verified the over-all superiority of digital tomography for post-extracorporeal shock wave lithotripsy imaging. Calculus detection by conventional and digital tomography is superior to detection by plain abdominal radiography. However, because we did not perform delayed imaging, it is not possible to say what impact digital tomography might have on the management of extracorporeal shock wave lithotripsy patients. 相似文献
4.
Noel R. Fajardo Filippo Cremonini Dr Nicholas J. Talley 《American Journal of Cancer》2006,5(5):319-330
In patients with cancer, constipation is a common complication. However, unlike in the general population, the impact of the symptoms of constipation on the quality of life in cancer patients is often greater. More importantly, in patients who are in the more advanced stages of the disease, constipation may also be suggestive of disease progression. Constipation as a symptom in this population is of significant importance as it may lead to life-threatening complications, i.e. bowel perforation due to fecal impaction. Therefore, in this regard, this problem deserves particular attention, as early recognition and management of complications may prevent further physical deterioration. This review aims to provide an overview of the management of constipation in patients with cancer. A symptom-based criteria definition for chronic constipation and prevalence of the problem in cancer patients provides a brief introduction. For the initial assessment and evaluation of constipation in cancer patients, an algorithm is described. The different possible etiologies of constipation in cancer patients are also discussed. Regarding therapeutic management, guidelines and recommendations for the use of different types of laxatives, stool softeners, suppositories and rectal enemas, prokinetic agents, antidepressant medications, and miscellaneous agents are succinctly discussed. Management of fecal impaction and opioid-induced bowel dysfunction are also described. Lastly, a brief overview of the management of acute colonic pseudo-obstruction and surgical or endoscopic options for large bowel obstruction are described. 相似文献
5.
6.
7.
8.
Factors influencing women to undergo screening mammography 总被引:2,自引:0,他引:2
9.
10.